Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714153 · ClinicalTrials.gov registry record · NA
Bridge Occlusion Balloon in Lead Extraction Procedure
A NA study of C.Surgical Procedure; Cardiac and Cardiac Dysrhythmia, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 7
- Study locations
NCT02714153: Completed NA study of C.Surgical Procedure; Cardiac and Cardiac Dysrhythmia, sponsored by Yale University.
NCT02714153 is a NA study of C.Surgical Procedure; Cardiac and Cardiac Dysrhythmia that has completed, run by Yale University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02714153, a NA study of C.Surgical Procedure; Cardiac and Cardiac Dysrhythmia, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 7
- Study locations
Study Summary
To evaluate the use of an occlusion balloon (Bridge™ Occlusion Balloon, Spectranetics) within the Superior Vena Cava in lead extraction patients.
Primary Outcome
After Bridge Balloon deployment and inflation, the degree of blood vessel occlusion will be reported. Measurements will be calculated from fluoroscopic images (using x-ray machine) and venograms (images with injection of contrast agent). Successful balloon occlusion of the superior vena cava (SVC) is defined as \>90% occlusion of the SVC by visual estimate using conventional venography.
Conditions Studied
Interventions
- DEVICE Bridge Balloon
Study Locations (7)
North Carolina
- Sanger Heart & Vascular Institute Carolinas HealthCare System - Charlotte
- Duke University Medical Center - Durham
Florida
- University of Miami Hospital - Miami
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- United Hospital - Saint Paul
New Jersey
- Cooper University Health Care - Camden
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT02714153 record still lists
NCT02714153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with C.Surgical Procedure; Cardiac appearing as the primary indexed condition, and to 1 intervention - of which Bridge Balloon is the first listed.
NCT02714153 lists 7 locations in 6 states (North Carolina, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02714153 about?
NCT02714153 is a clinical study titled "Bridge Occlusion Balloon in Lead Extraction Procedure". To evaluate the use of an occlusion balloon (Bridge™ Occlusion Balloon, Spectranetics) within the Superior Vena Cava in lead extraction patients.
What is the current status of trial NCT02714153?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-04. Estimated completion is 2017-10.
What conditions does trial NCT02714153 study?
This clinical trial studies the following conditions: C.Surgical Procedure; Cardiac, Cardiac Dysrhythmia, Disorder of Pacing Function.
What interventions are being tested in trial NCT02714153?
The interventions under investigation include: Bridge Balloon (DEVICE).
Who is sponsoring clinical trial NCT02714153?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02714153 being conducted?
This trial has 7 study locations across Florida, Massachusetts, Minnesota, New Jersey, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for C.Surgical Procedure; Cardiac
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02714153's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia